Delivery Order SPE2DB25D3020-SPE2DB25FWJTD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Eliquis 2.5 mg tablets (60-count packages). This non-set-aside, competitively awarded contract represents a firm fixed price delivery order with an ultimate completion date of July 22, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a $10,308.12 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Eliquis 5 mg tablets (60-count packages). This is a firm fixed price, non-set-aside contract with a completion date of July 22, 2025, and performance location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order represents a relatively small transaction within the company's extensive federal pharmaceutical...
- The Defense Logistics Agency awarded a $1,883.70 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Eliquis 2.5 mg tablets (60-count). This firm fixed-price contract is non-set-aside and scheduled for completion by July 24, 2025, with performance taking place at the contractor's headquarters in Conshohocken, Pennsylvania. The delivery order represents a single pharmaceutical procurement under AmerisourceBergen's existing contract vehicle with the agency. This award...
- The Defense Logistics Agency awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for Eliquis 5 mg tablets (60-count supply) on July 21, 2025, with completion targeted for July 22, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and reflects standard pharmaceutical procurement through the federal medical supply chain. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $17,178.08 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60 count) on July 21, 2025, with a completion date of July 22, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count packaging) on July 25, 2025, with completion scheduled for July 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $3,776.22 to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Eliquis 5 mg tablets (60-count units). This is a firm fixed price delivery order with no set-aside designation, representing a competitive award under the company's existing indefinite delivery contract vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,195.60 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count) on July 31, 2025, with a completion date of August 1, 2025. The award was made on a firm fixed-price basis with no set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is one of the nation's leading pharmaceutical distributors and serves as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Eliquis 5 mg tablets in a 60-count package, valued at $12,551.21. This firm fixed-price delivery order is scheduled for completion by August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's demonstrated...
- The Defense Logistics Agency awarded a delivery order valued at $19,111.33 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This contract, executed on July 29, 2025, with an ultimate completion date of July 30, 2025, utilizes firm fixed-price pricing and was competitively awarded without any set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB25FWJTDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count packages) on July 29, 2025, with completion targeted for July 30, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The pharmaceutical will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate headquarters and primary distribution point for federal medical procurement. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This prime indefinite delivery vehicle supports military healthcare programs globally by providing comprehensive pharmaceutical and medical supply services across multiple therapeutic domains. The contract enables AmerisourceBergen to serve the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen maintains an extensive portfolio of federal medical product deliveries, demonstrating capability to meet DLA requirements through open competition across diverse product categories and order values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 7/29/25 |